GSK plc
GSK
#176
Rank
A$171.54 B
Marketcap
A$85.03
Share price
3.51%
Change (1 day)
57.73%
Change (1 year)

Market capitalization of GSK plc (GSK)

Market cap: A$171.54 Billion

As of February 2026 GSK plc has a market cap of A$171.54 Billion. This makes GSK plc the world's 176th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GSK plc from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$171.54 B15.68%
2025A$148.29 B32.66%
2024A$111.78 B-0.12%
2023A$111.92 B5.88%
2022A$105.70 B-29.76%
2021A$150.49 B26.11%
2020A$119.34 B-28.21%
2019A$166.23 B24.66%
2018A$133.34 B18.14%
2017A$112.87 B-13.65%
2016A$130.71 B-3.87%
2015A$135.97 B6.83%
2014A$127.28 B-12%
2013A$144.63 B42.11%
2012A$101.77 B-9.41%
2011A$112.34 B11.99%
2010A$100.31 B-17.82%
2009A$122.07 B-10.9%
2008A$137.00 B-13.69%
2007A$158.74 B-17.59%
2006A$192.61 B-4.36%
2005A$201.40 B10.78%
2004A$181.80 B2.62%
2003A$177.16 B-11.54%
2002A$200.27 B-33.53%
2001A$301.30 B-4.37%
2000A$315.07 B103.55%
1999A$154.78 B-24.78%
1998A$205.77 B56.66%
1997A$131.34 B85.38%
1996A$70.85 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of GSK plc was reported to be:

A$167.54 Billion
by Nasdaq info icon info icon
A$166.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$422.77 B 146.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$219.08 B 27.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$166.40 B-3.00%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$433.16 B 152.51%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$842.84 B 391.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$58.87 B-65.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
A$2.61 B-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA